MYB and adrenal cortex carcinoma: Frerich C.A et al. provided evidence that ACC tumors may use an alternative MYB promoter, named TSS2, leading to the expression of N-terminally truncated MYB proteins (ΔN Myb) with distinct functional activities [23].